Tripathi Ashish Kumar, Sardar Anirban, Rai Nikhil, Rai Divya, Girme Aboli, Sinha Shradha, Chutani Kunal, Hingorani Lal, Mishra Prabhat Ranjan, Trivedi Ritu
Endocrinology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
ACS Pharmacol Transl Sci. 2024 Aug 19;7(9):2621-2636. doi: 10.1021/acsptsci.3c00356. eCollection 2024 Sep 13.
Obesity and osteoporosis are two prevalent conditions that are becoming increasingly common worldwide, primarily due to aging populations, imbalanced energy intake, and sedentary lifestyles. Obesity, characterized by excessive fat accumulation, and osteoporosis, marked by reduced bone density and increased fracture risk, are often interconnected. High-fat diets (HFDs) can exacerbate both conditions by promoting bone marrow adiposity and bone loss. The effect of WFA on the osteogenesis and adipogenesis was studied on the C3H10T1/2 cell line and bone marrow mesenchymal stem cells (BM-MSCs) isolated from mice. We used oil red O and alkaline phosphatase (ALP) staining to observe adipogenesis and osteogenesis, respectively, in MSCs. Real-time PCR and Western blot analyses were used to study the molecular effects of WFA on MSCs. We employed micro-CT to analyze the bone microarchitecture, bone mineral density (BMD), and abdominal fat mass in male mice. We have used osmium tetroxide (OsO) staining to study the bone marrow fat. WFA induced the C3H10T1/2 cell line and BM-MSCs toward osteogenic lineage as evidenced by the higher ALP activity. WFA also downregulated the lipid droplet formation and adipocyte specific genes in MSCs. In the study, WFA also suppressed the bone catabolic effects of the HFD and maintained the bone microarchitecture and BMD in WFA-treated animals. The bone marrow adipose tissue was reduced in the tibia of WFA-treated groups in comparison with only HFD-fed animals. Withaferin A was able to improve the bone microarchitecture and BMD by committing BM-MSCs toward osteogenic differentiation and reducing marrow adiposity. The findings of this study could provide valuable insights into the therapeutic potential of Withaferin A for combating bone marrow obesity and osteoporosis, particularly in the context of diet-induced metabolic disturbances.
肥胖和骨质疏松是两种在全球范围内日益普遍的疾病,主要归因于人口老龄化、能量摄入不均衡以及久坐不动的生活方式。肥胖的特征是脂肪过度堆积,而骨质疏松则表现为骨密度降低和骨折风险增加,这两种疾病常常相互关联。高脂饮食(HFDs)会通过促进骨髓脂肪生成和骨质流失,使这两种疾病恶化。本研究在C3H10T1/2细胞系以及从小鼠分离出的骨髓间充质干细胞(BM-MSCs)上,研究了白荚果醇(WFA)对成骨作用和脂肪生成的影响。我们分别使用油红O染色和碱性磷酸酶(ALP)染色来观察间充质干细胞中的脂肪生成和成骨作用。通过实时聚合酶链反应(PCR)和蛋白质免疫印迹分析来研究WFA对间充质干细胞的分子作用。我们采用显微计算机断层扫描(micro-CT)来分析雄性小鼠的骨微结构、骨矿物质密度(BMD)和腹部脂肪量。我们使用四氧化锇(OsO)染色来研究骨髓脂肪。较高的ALP活性表明,WFA诱导C3H10T1/2细胞系和BM-MSCs向成骨谱系分化。WFA还下调了间充质干细胞中脂滴的形成以及脂肪细胞特异性基因。在本研究中,WFA还抑制了高脂饮食对骨骼的分解代谢作用,并在接受WFA治疗的动物中维持了骨微结构和骨矿物质密度。与仅喂食高脂饮食的动物相比,接受WFA治疗组的小鼠胫骨中的骨髓脂肪组织减少。白荚果醇A能够通过促使BM-MSCs向成骨分化并减少骨髓脂肪生成,来改善骨微结构和骨矿物质密度。本研究结果可为白荚果醇A在对抗骨髓肥胖和骨质疏松方面的治疗潜力提供有价值的见解,尤其是在饮食诱导的代谢紊乱背景下。